References: | Schwarting, R., Gerdes, J., Durkop, H., Falini, B., Pileri, S., & Stein, H. (1989). BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope.Blood,74(5), 1678-1689. Beljaards, R. C., Meijer, C. J., Scheffer, E., Toonstra, J., Van Vloten, W. A., Van Der Putte, S. C., ... & Willemze, R. (1989). Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.The American journal of pathology,135(6), 1169. Horie, R., & Watanabe, T. (1998, December). CD30: expression and function in health and disease. InSeminars in immunology(Vol. 10, No. 6, pp. 457-470). Academic Press. |